drug · protein
patient view →etelcalcetide hydrochloride
Marketedupdated 2mo agoby $AMGN AMGEN INC🔗 ChEMBL
Approvedcommunity read0 votes
Protein drug with a maximum clinical stage of Approval (across all indications), with an approval for secondary hyperparathyroidism and chronic kidney disease.
targets
Extracellular calcium-sensing receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that